Solventum (FRA:KB7) Other Current Liabilities: €703 Mil (As of Mar. 2026)


FRA:KB7 Solventum Corp FRA:KB7
26 GF Score
Price €65.00
! 6 Warning Signs
View Full Analysis

What is Solventum Other Current Liabilities?

Solventum FRA:KB7 -2.99% 26 Other Current Liabilities is €703 Mil as of Mar. 2026. GuruFocus rates FRA:KB7 with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Solventum's other current liabilities for the quarter that ended in Mar. 2026 was €703 Mil.

Solventum's quarterly other current liabilities increased from Sep. 2025 (€686 Mil) to Dec. 2025 (€815 Mil) but then declined from Dec. 2025 (€815 Mil) to Mar. 2026 (€703 Mil).

Solventum's annual other current liabilities increased from Dec. 2023 (€335 Mil) to Dec. 2024 (€629 Mil) and increased from Dec. 2024 (€629 Mil) to Dec. 2025 (€815 Mil).

Solventum Other Current Liabilities Related Terms

Solventum Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Solventum's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solventum Other Current Liabilities Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 285.86 222.78 334.71 629.35 814.72

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 559.63 595.63 685.86 814.72 703.25
FRA:KB7
26GF Score
Solventum Corp FRA:KB7
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solventum Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €703 Mil mean?
Solventum (FRA:KB7) has a Other Current Liabilities of €703 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Solventum.
Is Solventum's Other Current Liabilities too high?
Solventum's current Other Current Liabilities is €703 Mil. Overall, Solventum has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's Other Current Liabilities compare to COO and ALGN?
Solventum's Other Current Liabilities of €703 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Solventum. Solventum's current Other Current Liabilities is €703 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (FRA:KB7) has a current Other Current Liabilities of €703 Mil. The current Other Current Liabilities is €703 Mil. Solventum's overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Solventum (FRA:KB7), the current Other Current Liabilities is €703 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solventum Business Description

Address 2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
26GF Score

Get the complete analysis for FRA:KB7

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price